Announcements
8 May 2025
International Thalassaemia Day—“Together for Thalassaemia: Uniting Communities, Prioritizing Patients”, 8 May 2025
Celebrated on 8 May, International Thalassaemia Day is dedicated to raising awareness among the general public and decision-makers about thalassaemia, supporting the lifelong and challenging journey of patients living with this severe blood disease, and honouring the memory of those we have lost, while renewing our commitment to finding a final cure.
Thalassaemia is more than just a disease. It transcends numbers and statistics, touching the lives of real people with real challenges and lived experiences. This year, we proudly embrace the theme, “Together for Thalassaemia: Uniting Communities, Prioritizing Patients”, and stand united under the powerful slogans “#WeAre1” and “PatientsFirst”.
In recognition of this important day, we recommend the following related articles, Special Issues, and journals spanning multidisciplinary fields, including clinical medicine. We believe that promoting such research contributes to enhanced public awareness and a greater understanding of thalassaemia.
 |
 |
 |
“Childhood Anemia in Mozambique: A Multilevel Mixed-Effects Analysis of 2011–2022/23 Population-Based Surveys”
by Réka Maulide Cane, Rornald Muhumuza Kananura, Ronald Wasswa, Maria Patrícia Gonçalves, Luís Varandas and Isabel Craveiro
Healthcare 2025, 13(6), 635; https://doi.org/10.3390/healthcare13060635
“Challenges of Iron Chelation in Thalassemic Children”
by Alkistis Adramerina and Marina Economou
Thalass. Rep. 2024, 14(1), 1-9; https://doi.org/10.3390/thalassrep14010001
“A Case Report of Hyperhemolytic Syndrome in Sickle Cell Disease, with a Special Focus on Avoiding the Use of Transfusions”
by Omar Obajed Al-Ali, György Pfliegler, Ferenc Magyari, Fanni Borics, László Imre Pinczés, Árpád Illés and Boglárka Brúgós
Thalass. Rep. 2024, 14(1), 18-25; https://doi.org/10.3390/thalassrep14010003
“Vamifeport: Monography of the First Oral Ferroportin Inhibitor”
by Federica Pilo and Emanuele Angelucci
J. Clin. Med. 2024, 13(18), 5524; https://doi.org/10.3390/jcm13185524
“Prognostic Role of Multiparametric Cardiac Magnetic Resonance in Neo Transfusion-Dependent Thalassemia”
by Antonella Meloni, Laura Pistoia, Paolo Ricchi, Aurelio Maggio, Valerio Cecinati, Filomena Longo, Francesco Sorrentino, Zelia Borsellino, Alessandra Salvo, Vincenza Rossi et al.
J. Clin. Med. 2024, 13(5), 1281; https://doi.org/10.3390/jcm13051281
“Pancreatic T2* Magnetic Resonance Imaging for Prediction of Cardiac Arrhythmias in Transfusion-Dependent Thalassemia”
by Antonella Meloni, Laura Pistoia, Paolo Ricchi, Vincenzo Positano, Filomena Longo, Zelia Borsellino, Valerio Cecinati, Giuseppe Messina, Elisabetta Corigliano, Rosamaria Rosso et al.
J. Clin. Med. 2023, 12(18), 6015; https://doi.org/10.3390/jcm12186015
“Health-Related Quality-of-Life Profile of Pediatric Patients with β Thalassemia after Hematopoietic Stem Cell Transplantation”
by Olga Mulas, Fabio Efficace, Maria Grazia Orofino, Antonio Piroddi, Eugenia Piras, Adriana Vacca, Susanna Barella, Alessandro Costa, Johannes M. Giesinger, Giorgio La Nasa et al.
J. Clin. Med. 2023, 12(18), 6047; https://doi.org/10.3390/jcm12186047
“Association between Glomerular Filtration Rate and β-Thalassemia Major: A Systematic Review and Meta-Analysis”
by Shahad Saif Khandker, Nurani Jannat, Deepannita Sarkar, Alif Hasan Pranto, Ismoth Ara Hoque, Jemema Zaman, Md. Nizam Uddin and Ehsan Suez
Thalass. Rep. 2023, 13(3), 195-205; https://doi.org/10.3390/thalassrep13030018
“Bone Marrow Transplantation in Nonmalignant Haematological Diseases: What Have We Learned about Thalassemia?”
by Luca Castagna, Stefania Tringali, Giuseppe Sapienza, Roberto Bono, Rosario Di Maggio and Aurelio Maggio
Thalass. Rep. 2023, 13(2), 122-130; https://doi.org/10.3390/thalassrep13020011
|
“Emerging Therapies and Strategies in Thalassemia: Toward a New Era in Management—2nd Edition” |
|
 |
 |
